Training and Education

DMT-assisted therapy: changing the way we think about depressive disorders

A ‘spirit molecule’ from the Amazon could be a game changer in the treatment of major depressive disorders. Dr Carol Routledge, of Small Pharma, talks to Karen Southern about her pioneering work with DMT. Psychedelic assisted drug therapy is not...

2022: The year for UK Life Sciences?

Charles Walford, Senior Development Director and Head of Life Sciences, Stanhope PLC, considers the opportunities and challenges facing the UK’s life sciences ecosystem. The past two years have propelled life sciences into the mainstream. The sector had already seen strong...

Personalised medicine: driving a need for greater diversity

Kate Shaw, CEO of Innovative Trials, investigates one of the biggest challenges facing clinical research today. Personalised medicines, particularly gene and cell therapies, offer new opportunities for treating serious conditions such as muscular dystrophy, cystic fibrosis and other complex conditions like...

Acesis breaks new ground with novel therapy solution to low testosterone

For the first time in over 70 years, a new testosterone replacement therapy has been unveiled. Dr Vassilios Papadopoulos and Dr Costas Karatzas, co-founders of Acesis BioMed, explain how their ‘first-in-class’ peptide therapeutics could transform men’s health across the...

Is your Invention Plausible?

Alex Bone, Patent Attorney, Partner,  AA Thornton The market exclusivity provided by a patent can be crucial for allowing a company to obtain a return on their R&D investment. A patent is essentially a deal in which, in return for an applicant...

AI used to improve cardiovascular risk prediction

AI startup Owkin and Amgen have announced the results of a three-year project using artificial intelligence to more accurately predict cardiovascular risk. This study demonstrates the ability of AI to improve the way that clinicians predict patients’ risk of...

Lab-grown ‘mini-stomachs’ could shed light on children’s COVID symptoms

A ‘lab-grown model’ of the human stomach, that can be used to study how infections affect the gastrointestinal system, has been developed for the first time. A UCL-led team of international scientists have built on recent advances to grow ‘mini-organs’...

Bacteria can develop strong immunity for protection against viruses

A new study hopes to exploit newly characterised defence systems in bacteria to compare changes to the human genome. University bioscientists have been working on the research to demonstrate the complex workings of bacterial innate immunity. Bacteria have evolved a multitude...

Ancient genes help dolphins live on

Ancient genes that predate the last Ice Age may be the key to survival … at least if you are a dolphin! Genes up to 2.3 million years old helped the bottlenose dolphin adapt to new habitats through changes in...

Light therapy helmet could help dementia patients

A new infrared light therapy has the potential to help people with dementia. A pilot study recently investigated how transcranial photobiomodulation therapy (PBM-T) –transferred through a specially adapted helmet -- could boost memory, motor function and processing skills in healthy...

Putting the diverse into neurodiversity

The global Institute Of Neurodiversity ION has launched its UK chapter. The Institute aims to give a global voice to all neurodiverse groups, and ensure neurodivergent individuals are understood, represented, and valued equally in society. Currently, 1 in 7 people in the UK...

Sizzling breakthrough for 3D meat

A 4oz steak has been ‘lab-grown’ using a digital design file. Israeli firm MeaTech 3D Ltd. cultivated the bio-printed steak using real fat and muscle cells. The cells were produced using an advanced process that starts by isolating ethically harvested...

‘Super jelly’ can survive being run over by a car

Researchers have developed a jelly-like material that can withstand the equivalent of an elephant standing on it, and completely recover to its original shape, even though it’s 80 per cent water. The soft-yet-strong material, developed by a team at the...

Teaching old oaks new tricks

Mature oak trees will increase their rate of photosynthesis by up to a third in response to the raised CO2 levels expected to be the world average by about 2050, new research shows. The results, published in Tree Physiology, are the first...

New microscope uses photonics for insights into ‘superbugs’

Scientists are building a new super-resolution microscope that uses laser light to study the inner workings and behaviours of superbugs to gain new insights into how they cause disease. The microscope will allow scientists to peer into bacteria like at a...

Spider web secrets unravelled

American scientists are the first to document every step of web-building. Johns Hopkins University researchers discovered precisely how spiders build webs by using night vision and artificial intelligence to track and record every movement of all eight legs as spiders...

USA Based Angstrom Technology Acquire UK Market-Leader Connect 2 Cleanrooms

ASGARD Partners & Co., LLC ("ASGARD"), a New York-based private equity firm, today announced that its portfolio company, Angstrom Technology ("Angstrom" or the "Company"), an industry leader in modular cleanroom design and production, has signed an agreement to acquire Lancaster,...

Connect 2 Cleanrooms and RoslinCT partner to introduce new GMP Cell and Gene Therapy Facility

Connect 2 Cleanrooms (C2C), in partnership with RoslinCT, is pleased to present the new state-of-the-art GMP manufacturing facility and training laboratory at RoslinCT’s BioCube building in Edinburgh’s BioQuarter. RoslinCT is a cell therapy Contract Development and Manufacturing Organisation (CDMO) working...

Shaping the science of oncology

Dr Fiona McLaughlin is the new Chief Scientific Officer of Avacta’s Therapeutics Division. She talks to Karen Southern about her mission to develop first and best-in-class cancer drugs. From the day that Dr McLaughlin – then a biochemistry student –...

Biotech pioneer tackles the biology of ageing

Living to a ripe old age is one thing. Enjoying a healthy, ripe old age is the challenge. Biotech veteran Dr Eric Leire aims to slow ageing by design, as he explains to Karen Southern. The quest for immortality (or...

Euro biotech: breaking down the barriers to a golden age

Converting cutting-edge research into viable products remains a challenge for the European biotech sector. Jonathan Hay of Delin Ventures investigates how ambition can translate to reality. Europe’s tech sector is going from strength to strength. The Covid-19 pandemic – and...

Biosample provenance: what researchers need to know

Why is the current system for sourcing samples broken? And what does this mean for researchers who use biosamples? Robert Hewitt, MB BS, PhD, of Biosample Hub, investigates. The journey for every biospecimen used for medical research is different. It...

Pioneering breakthrough in treatment of ‘devastating’ neurological disorder

IntraBio Inc has announced positive data from its multinational clinical trial of IB1001 for the treatment of GM2 Gangliosidosis (Tay-Sachs and Sandhoff disease). IB1001 demonstrated a statistically significant and clinically meaningful improvement in symptoms, functioning, and quality of life in...

Covid portal start-up exceeds 1 million tests and creates offshoot venture

As the UK continues learning how to live with the pandemic, some key questions remain. Chiefly, how will the NHS grapple with the huge diagnosis and treatment backlog that has built up, and will the NHS become even more...

New clinical study into R-ketamine use for Treatment Resistant Depression

A clinical study to evaluate the safety and efficacy of PCN-101 (R-ketamine) has entered a new phase. R-ketamine is a stereoisomer of ketamine being developed for therapeutic treatment of psychiatric disorders such as Treatment Resistant Depression (TRD). The Phase 2a clinical...

Cleaning breakthrough for listeria elimination

All traces of listeria spp in a highly sensitive food production environment have been successfully eliminated in a breakthrough pilot. The 11-week proof of concept saw Bio-Fence antimicrobial coatings applied to the floor and lower part of walls of a...

AI could improve diagnosis for over 100,000 prostate patients in UK

The use of AI to identify prostate cancer is currently being validated in the first retrospective study of its kind in the UK. Real-world data from hospitals and scanner types is being scrutinised, to show how the technology could improve...

Advances in longitudinal RWD and genomics access for drug development in Africa

A new partnership aims to build the largest integrated clinical and genomics data biobank in Africa, representing a major boost for RWD research across the continent. The collaboration is between BC Platforms (BCP), a global leader in genomics research, analytics...

Ultrapure water system passes big test

An innovative ultrapure water system has successfully tapped into healthcare diagnostics. The pharmaceutical industry is embracing new technology that can reduce costs and simplify installation. At the production site of a multinational healthcare diagnostic test manufacturer, Bürkert’s FLOWave has proven...

Lung cancer treatment is a UK first

A grandfather has become the UK’s first lung cancer patient to benefit from a state-of-art radiotherapy treatment at The Christie NHS Foundation Trust. Barry Staniforth, 81, was treated using the Elekta MR-guided linear accelerator (MR-linac) machine that performs real-time MRI...